Showing results (121-130 of 325) with videos related to
Sort By:
Pageof 33
International Journal of Hematology|October 15, 2009
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemiaShiho Fujiwara, Hirosada Miyake, Kisato Nosaka, et al.Experimental Hematology & Oncology|April 25, 2015
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1Shiho Fujiwara, Naoko Wada, Yawara Kawano, et al.Journal of Medicinal Chemistry|June 25, 2015
Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studiesArun K Ghosh, Xufen Yu, Heather L Osswald, et al.Microbiology Spectrum|October 31, 2022
Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug EvaluationNobuyo Higashi-Kuwata, Shigeharu G Yabe, Satsuki Fukuda, et al.Journal of Pharmacological Sciences|May 4, 2021
Effects of islatravir (4'-ethynyl-2-fluoro-2'-deoxyadenosine or EFdA) on renal tubular cells and islatravir's interactions with organic anion transportersMeika Kaneko, Yoshie Reien, Hanae Morio, et al.Molecular Cancer Therapeutics|July 16, 2005
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent mannerHiro Tatetsu, Yutaka Okuno, Miki Nakamura, et al.Molecular Pharmaceutics|September 26, 2014
Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemiaYuri Miyazaki, Kazuaki Taguchi, Keitaro Sou, et al.Journal of Medicinal Chemistry|September 12, 2008
Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studiesArun K Ghosh, Sandra Gemma, Abigail Baldridge, et al.Antimicrobial Agents and Chemotherapy|June 24, 2009
Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout miceShinichiro Hattori, Kazuhiko Ide, Hirotomo Nakata, et al.International Journal of Hematology|April 28, 2009
Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemiaTatsuya Kawaguchi, Akinobu Hamada, Chie Hirayama, et al.Pageof 33